Table 1. Included meta-analyses.
| Meta-analysis | Target parameter | Exposure parameter | Review period | Included studies*1 | Study cohorts*1 |
| Ni Mhurchu et al. (e8) | Stroke, coronary heart disease | BMI | Not specified | n = 4 | M, F (Australia/New Zealand) |
| Bergström et al. (e12) | Renal cell carcinoma | BMI | 1966–1998 | n = 6 | M, F*2 |
| Berrington de Gonzalez et al. (e28) | Pancreatic cancer | BMI | 1966–2003 | n = 8 | M, F (EU, USA) |
| Beuther et al. (e32) | Asthma | BMI | 1966–2006 | n = 7 | M, F (EU, USA, Canada) |
| Bogers et al. (e6) | Coronary heart disease | BMI | 1996–2005 | n = 14 | M, F (EU, USA, Canada) |
| Connolly et al. (e13) | Breast cancer | WHR | 1966–2002 | n = 5 | F (EU, USA) |
| Dai et al. (e14) | Colon cancer, rectal cancer | BMI, WC, WHR | Until Dec 2006 | n = 15 | M, F (EU, USA, Canada, Australia, Asia) |
| de Laet et al. (e11) | Bone fractures | BMI | Not specified | n = 12 | M, F (EU, Canada, Asia) |
| Hartemink et al. (e9) | Type 2 diabetes | BMI | 1980–2004 | n = 31 | M, F (EU, USA) |
| Harvie et al. (e15) | Breast cancer | WHR | 1966–2002 | n = 5 | F (EU, USA) |
| Janssen et al. (e4) | All cause mortality | BMI | Not specified | n = 32 | M, F (EU, USA, Asia) Age >65 years |
| de Koning et al. (e5) | Cardiovascular events | WC, WHR | 1966–2006 | n = 15 | M, F*2 |
| Larsson et al. (e19) | Non-Hodgkin’s lymphoma | BMI | 1966–2007 | n = 10 | M, F (EU, USA, Australia, Asia) |
| Larsson et al. (e17) | Multiple myeloma | BMI | 1966–2007 | n = 11 | M, F (EU, USA, Australia, Asia) |
| Larsson et al. (e22) | Hepatic cell carcinoma | BMI | 1966–2007 | n = 11 | M, F (EU, USA, Asia) |
| Larsson et al.(e20) | Gallbladder cancer | BMI | 1966–2007 | n = 8 | M, F (EU, USA, Asia) |
| Larsson et al. (e16) | Pancreatic cancer | BMI | 1966–2006 | n = 21 | M, F (EU, USA, Asia) |
| Larsson et al. (e21) | Leukemia | BMI | 1966–2007 | n = 9 | M, F (EU, USA, Australia, Asia) |
| Larsson et al. (e18) | Colon cancer, rectal cancer | BMI, WC, WHR | 1966–2007 | n = 31 | M, F (EU, USA, Canada, Australia, Asia) |
| MacInnes et al. (e24) | Prostate cancer | BMI, WC | 1966–2004 | n = 23 | M (EU, USA) |
| McGee (6) | All cause mortality, overall cancer mortality, coronary heart disease, cardiovascular events | BMI | Not specified | n = 26 | M, F*2 |
| Moghaddam et al. (e23) | Colorectal cancer | BMI, WC | Until April 2007 | n = 23 | M, F (EU, USA, Canada, Australia, Asia) |
| Olsen etal. (e25) | Epithelial ovarian cancer | BMI | Until April 2006 | n = 11 | F*2 |
| Renehan et al. (e26) | Total cancers | BMI | Until Nov 2007 | n = 67 | M, F (EU, USA, Australia, Asia) |
| Ursin et al. (e27) | Breast cancer | BMI | 1966–1992 | n = 4 | F (EU) |
| Wanahita et al. (e7) | Atrial fibrillation | BMI | 1966–2007 | n = 5 | M, F (EU, USA) |
| Wang et al. (e29) | Renal cell carcinoma | BMI | 1980–2006 | n = 16 | M, F (EU, USA, Asia) |
EU, European population; F, females; M, males
*1 Only meta-analyses of prospective population-related cohort studies are listed
*2 No information is available on the origin of the included cohorts